NCT00608361 2015-07-02Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By SurgeryNational Cancer Institute (NCI)Phase 1 Completed80 enrolled
NCT01158274 2014-11-07RO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsNational Cancer Institute (NCI)Phase 1 Completed30 enrolled
NCT00073944 2013-05-30BCX-1777 in Treating Patients With Refractory CancerNational Cancer Institute (NCI)Phase 1 Completed